Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
cancer therapeutics Market Research Reports
cancer therapeutics Market Research Reports
| Title | published | price | |
|---|---|---|---|
Recurrent Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... he Recurrent Glioblastoma Multiforme (GBM) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Recurrent Glioblastoma Multiforme (GBM), complete with analysis by Stage of Developmen......" | 02-May-2022 | $2500 | |
CNS Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... eport provides comprehensive information on the therapeutics under development for CNS Lymphoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also ......" | 02-May-2022 | $2000 | |
Bone Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... eport provides comprehensive information on the therapeutics under development for Bone Sarcoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also ......" | 02-May-2022 | $2500 | |
Recurrent Head And Neck Cancer Squamous Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... yers provides an overview of the Recurrent Head And Neck Cancer Squamous Cell Carcinoma pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Recurrent Head And Neck Cancer Squamous C......" | 02-May-2022 | $2500 | |
Malignant Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... />
The report provides comprehensive information on the therapeutics under development for Malignant Ascites, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Ty......" | 02-May-2022 | $2000 | |
Papillary Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... Cell Carcinoma pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Papillary Renal Cell Carcinoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action ......" | 02-May-2022 | $2000 | |
Primary Mediastinal B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ry Mediastinal B-Cell Lymphoma pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Primary Mediastinal B-Cell Lymphoma, complete with analysis by Stage of Development, Drug Target, ......" | 02-May-2022 | $2000 | |
Refractory Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... verview of the Refractory Chronic Lymphocytic Leukemia (CLL) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Refractory Chronic Lymphocytic Leukemia (CLL), complete with analysi......" | 02-May-2022 | $2500 | |
Mast Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... br />
The report provides comprehensive information on the therapeutics under development for Mast Cell Leukemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecul......" | 02-May-2022 | $2000 | |
Marginal Zone B-cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key PlayersBy Global Markets Direct "...... ell Lymphoma pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Marginal Zone B-cell Lymphoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA......" | 02-May-2022 | $2500 | |
| | |||